M. Frostvik Stolt

发表

Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis–Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer

Mårten Fernö, Srinivas Veerla, Siker Kimbung, 2015, Clinical Cancer Research.

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

J. Hansson, H. Johansson, Rainer Tuominen, 2017, BMC Cancer.

Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance

J. Hansson, J. Lehtiö, M. Pernemalm, 2014, British Journal of Cancer.

MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma

J. J. van den Oord, J. Hansson, H. Johansson, 2015, International journal of cancer.

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells

L. Kanter, J. Hansson, J. Lehtiö, 2017, Cell Death and Disease.

Real-time RT-PCR for the determination of topoisomerase II mRNA level in leukaemic cells.

A. Gruber, J. Liliemark, M. Frostvik Stolt, 2002, Leukemia research.

Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines

J. Hansson, S. Egyházi Brage, M. Frostvik Stolt, 2013, Melanoma research.

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma

S. Kauppinen, H. Olsson, C. Ingvar, 2020, bioRxiv.

Proteinase K added to the extraction procedure markedly increases RNA yield from primary breast tumors for use in microarray studies.

J. Bergh, J. Bjöhle, A. Borg, 2004, Clinical chemistry.

Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer

H. Johansson, E. Åvall-Lundqvist, J. Carlson, 2013, BMC Clinical Pathology.

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

M. Fernö, C. Perou, J. Bergh, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Metabolic Markers and HSP60 in Chemonaive Serous Solid Ovarian Cancer Versus Ascites

H. Johansson, E. Åvall-Lundqvist, M. Shoshan, 2014, International Journal of Gynecologic Cancer.

Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival.

M. Fernö, C. Perou, J. Bergh, 2015 .

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

J. Hansson, H. Johansson, Rainer Tuominen, 2017, BMC Cancer.

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma

P. Johnsson, D. Grandér, O. Sangfelt, 2021, Scientific Reports.